Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced data from a post hoc analysis of the GALE extension study following five years of continuous treatment with SYFOVRE® (pegcetacoplan ...
BlockDag has already surpassed $430 million in its presale and confirmed listings on some exchanges like MEXC, LBank, and Bitmart. While the BlockDag launch date has not yet been confirmed, the ...
Tests confirm graphene-based energy harvesters can use ambient energy to run ultra-low power sensors — the first hurdle in developing autonomous sensor systems.